This invention relates to novel 3-aminopyridines of the formula
wherein B1, B2 and R1 to R6 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.
[EN] POLYSUBSTITUTED PYRIDINE COMPOUND, PREPARATION METHOD, USE AND PHARMACEUTICAL COMPOSITION<br/>[FR] COMPOSÉ DE PYRIDINE POLYSUBSTITUÉ, SON PROCÉDÉ DE PRÉPARATION, SON UTILISATION ET COMPOSITION PHARMACEUTIQUE EN CONTENANT<br/>[ZH] 多取代的吡啶化合物、制备方法、用途及药物组合物